GHS forms official partnership with the Institute for OneWorld Health (iOWH)

iOWH is a non-profit drug development company that is headquartered in San Francisco and New Delhi. Its mission is to discover, develop, and deliver safe, effective, and affordable new treatments for neglected diseases afflicting children in the developing world. GHS and iOWH will collaborate on validating the safety and efficacy of novel plant-based rabies vaccines and anti-rabies immunoglobulins. iOWH will also provide valuable expertise and facilities for human clinical trials.